CIACC Milano, 3 Dicembre 2011 Strategie di trattamento nelle Sindromi Coronariche Acute senza ST sopraslivellato Corrado Lettieri U.O. di Cardiologia,
Statine e sindromi coronariche acute : evidenze per la scelta di un trattamento appropriato Dott Antonio Giomi Emodinamica AUSL 3 Pistoia Villa Cappugi.
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for noncardiac surgery Dr. Sonia Anand McMaster University.
Safety and Efficacy of Commercially Available Ultrasound Contrast Agents in the Clinical Setting Melda S. Dolan, MD; Simil Gala, MD; Saritha Dodla, MD;
MEND-CABG II ACC08 LBCT JHA, 1 John H. Alexander, MD, MS, FACC Robert W. Emery, MD, FACC On behalf of the MEND-CABG II Investigators A Randomized, Double-blind,
Seoul National University Hospital CILON-T Late Breaking Trial : Randomized prospective trial of dual vs. triple antiplatelet therapy after DES implantation.
Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` Rury R. Holman, MB, ChB, FRCP Professor of Diabetic Medicine Director, Diabetes.
Coronary Heart Disease & Depression : The Bi-Directional Relationship Madeleine Lloyd MS, RN, FNP, MHNP Ana Mola MA, RN, ANP.
1 Clinical Epidemiology Using Evidence to Guide Practice A bit of thinking and a few simple sums.
MEND-CABG II ACC08 LBCT JHA, 1 John H. Alexander, MD, MS, FACC On behalf of the MEND-CABG II Investigators A Randomized, Double-blind, Placebo-controlled,
Presenter: Otavio Berwanger (MD; PhD) on Behalf of the BRIDGE-ACS Steering Committe Sponsor: Ministry of Health-Brazil A Multifaceted Intervention to Narrow.
Listening to the Data: Why There’s Room for Improvement in MI Care Heartscape® Consultants Meeting Charles V. Pollack, Jr, MA, MD, FACEP, FAAEM, FAHA Chairman,